findmyKOL
Clinical trialNCT04671251CompletedPhase 1Interventional

Phase 1b Study of AEVI-007 in Subjects With Relapsed or Refractory Multiple Myeloma

SponsorAvalo Therapeutics, Inc.Enrollment13Multiple Myeloma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of California, Davis Comprehensive Cancer Center

    Sacramento, California, United States

  • James R. Berenson, Md., Inc.

    West Hollywood, California, United States

  • Florida Cancer Specialists

    Lake Mary, Florida, United States

  • Florida Cancer Specialists

    Sarasota, Florida, United States

  • American Oncology Partners of Maryland, Pa

    Bethesda, Maryland, United States

  • Levine Cancer Institute

    Charlotte, North Carolina, United States

  • Froedtert Hospital & the Medical College of Wisconsin

    Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
15 Dec 2020
Primary completion
30 Mar 2022
Completion
30 Mar 2022
Last update posted
29 Feb 2024
Registered enrollment
13
Registry id
NCT04671251

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.